Product Information
CIPROFLOXACIN HCL 250 MG TAB is a generic product labeled by Method Pharmaceuticals LLC, priced at $0.0910 per EA under NDC 58657067501. Its NADAC has been published 229 times since Jan 13, 2021.
FDA first approved this application on Jun 22, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Method Pharmaceuticals LLCNDC
58657067501
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
5/21/2025
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208921FDA Approved
6/22/2018
TE Code
AB
On Market Since
8/12/2020
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN HCL 250 MG TAB has been published 229 times since Jan 13, 2021, and over the history we have for it it has declined 8.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0910 per EA |
|---|---|
| All-time high | $0.1077 (Sep 15, 2021) |
| All-time low | $0.0811 (Nov 20, 2024) |
| Median price | $0.0974 |
| Average price | $0.0960 |
| Largest weekly change | -21.4% (Apr 17, 2024) |
| Weeks tracked | 229 |
| Tracking since | Jan 13, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-8.3%
5Y
-15.5%
All
-8.1%
Last surveyed May 28, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN HCL 250 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN HCL 250 MG TAB, manufactured by Method Pharmaceuticals LLC, is $0.0910 per EA (NDC 58657067501), effective May 28, 2025.
How has the price of CIPROFLOXACIN HCL 250 MG TAB changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has declined 8.1%. It has been tracked across 229 weekly CMS publications since Jan 13, 2021.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN HCL 250 MG TAB?
Since Jan 13, 2021, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has ranged from a low of $0.0811 (Nov 20, 2024) to a high of $0.1077 (Sep 15, 2021), with a median of $0.0974 per EA.
Are there cheaper alternatives to CIPROFLOXACIN HCL 250 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CIPROFLOXACIN HCL 250 MG TAB, is $0.0880 per EA — about 3% below CIPROFLOXACIN HCL 250 MG TAB.
Who manufactures CIPROFLOXACIN HCL 250 MG TAB?
CIPROFLOXACIN HCL 250 MG TAB (NDC 58657067501) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.